CORDIS
EU research results

CORDIS

English EN

European Proteomics Infrastructure Consortium providing Access

Objective

In life sciences research, proteomics technologies promise to be even more revolutionary than genomics for understanding the molecular mechanisms of complex biological systems and their (mal-)functions in health and disease. As a result, there is a strongly growing need for the integration of proteomic technologies into world-class life sciences research programs in medicine, agriculture, food, biotechnology, and materials.

The European Proteomics Infrastructure Consortium providing Access (EPIC-XS) brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. This will be achieved by providing access to cutting-edge proteomics facilities, and by developing and implementing novel mass spectrometry based proteomics and bioinformatics approaches to shape the future life sciences research in Europe.

The Transnational Access in EPIC-XS consists of around 2400 days of access to state-of-the-art proteomics facilities, corresponding to around 150 user projects, which will be evaluated by an independent review panel to ensure excellence, and to match users with the best facility for their challenging research questions.

The cutting-edge Joint Research Activities in EPIC-XS are built on the extremely strong innovation track record of the consortium members, and will address bottlenecks in, and develop novel approaches for, future-oriented efforts in computational and structural proteomics, analysis of higher-order proteome organization, multi-omics integration, and translational/clinical proteomics and personalized/precision medicine.

EPIC-XS will provide users with unrivalled access to world-leading facilities and expertise, while simultaneously extending Europe’s leading international role in the. EPIC-XS meets the widespread current demands for user access, addresses present bottlenecks in the field and will open up entirely new perspectives in proteomics.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITEIT UTRECHT

Address

Heidelberglaan 8
3584 Cs Utrecht

Netherlands

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 745 000,75

Participants (17)

Sort alphabetically

Sort by EU Contribution

Expand all

VIB

Belgium

EU Contribution

€ 1 351 127

KOBENHAVNS UNIVERSITET

Denmark

EU Contribution

€ 1 206 963,75

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

Switzerland

EU Contribution

€ 1 202 916

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

EU Contribution

€ 266 750

EBERHARD KARLS UNIVERSITAET TUEBINGEN

Germany

EU Contribution

€ 209 750

FUNDACIO CENTRE DE REGULACIO GENOMICA

Spain

EU Contribution

€ 523 349

FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III

Spain

EU Contribution

€ 480 782

KUNGLIGA TEKNISKA HOEGSKOLAN

Sweden

EU Contribution

€ 473 312,50

TECHNISCHE UNIVERSITAET MUENCHEN

Germany

EU Contribution

€ 524 202,50

MIKROBIOLOGICKY USTAV - AVCR, V.V.I.

Czechia

EU Contribution

€ 474 125

INSTITUT PASTEUR

France

EU Contribution

€ 499 282,25

ISTITUTO EUROPEO DI ONCOLOGIA SRL

Italy

EU Contribution

€ 488 125

FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH

Austria

EU Contribution

€ 208 500

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

EU Contribution

€ 120 500

IDRYMA TECHNOLOGIAS KAI EREVNAS

Greece

EU Contribution

€ 70 500

TARTU ULIKOOL

Estonia

EU Contribution

€ 70 500

UNIVERSITETET I BERGEN

Norway

EU Contribution

€ 70 500

Project information

Grant agreement ID: 823839

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.1.4.1.2.

  • Overall budget:

    € 9 986 185,75

  • EU contribution

    € 9 986 185,75

Coordinated by:

UNIVERSITEIT UTRECHT

Netherlands